Influence of platelet-activating factor on cerebral microcirculation in rats: Part 2. Local application

Stroke

Volumn 30, Issue 4, 1999, Pages 880-886

  Uhl, Eberhard ^a   Pickelmann, Sven ^a   Röhrich, Frank ^b   Baethmann, Alexander ^a   Schürer, Ludwig ^b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Cerebral circulation; Leukocytes; Microcirculation; Platelet activating factor; Rats

Indexed keywords

BEPAFANT; THROMBOCYTE ACTIVATING FACTOR; UNCLASSIFIED DRUG; WEB 2170BS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY DIAMETER; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CIRCULATION; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN MICROCIRCULATION; CONTROLLED STUDY; DOSE RESPONSE; HYPOTENSION; LEUKOCYTE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SHOCK; VASCULAR ENDOTHELIUM;

EID: 0032921981     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.30.4.880     Document Type: Article

References (34)

1. Braquet P, Touqui L, Shen TY, Vargaftig BB. Perspectives in platelet-activating factor research. Pharmacol Rev. 1987;39:97-145.
2. Yue TL, Feuerstein GZ. Platelet-activating factor: a putative neuro-modulator and mediator in the pathophysiology of brain injury. Crit Rev Neurobiol. 1994;8:11-24.
3. Tokumura A, Kamiyasu K, Takauchi K, Tsukatani H. Evidence for existence of various homologues and analogues of platelet activating factor in a lipid extract of bovine brain. Biochem Biophys Res Commun. 1987;145:415-425.
4. Yoshida J, Tokumura A, Fukuzawa K, Terao M, Takauchi K, Tsukatani H. A platelet-aggregating and hypotensive phospholipid isolated from bovine brain. J Pharm Pharmacol. 1986;38:878-882.
5. Domingo MT, Spinnewyn B, Chabrier PE, Braquet P. Changes in PAF binding and PAF concentrations in gerbil brain after bilateral common carotid artery occlusion: a quantitative autoradiographic study. Brain Res. 1994;640:268-276.
6. Satoh K, Imaizumi T, Yoshida H, Hiramoto M, Takamatsu S. Increased levels of blood platelet-activating factor (PAF) and PAF-like lipids in patients with ischemic stroke. Acta Neurol Scand. 1992;85:122-127.
7. Spinnewyn B, Blavet N, Clostre F, Bazan N, Braquet P. Involvement of platelet-activating factor (PAF) in cerebral post-ischemic phase in Mongolian gerbils. Prostaglandins. 1987;34:337-349.
8. Oberpichler H, Sauer D, Rossberg C, Mennel HD, Krieglstein J. PAF antagonist ginkgolide B reduces postischemic neuronal damage in rat brain hippocampus. J Cereb Blood Flow Metab. 1990;10:133-135.
9. Dillon PK, Duran WN. Effect of platelet-activating factor on microvascular permselectivity: dose-response relations and pathways of action in the hamster cheek pouch microcirculation. Circ Res. 1988;62:732-740.
10. Bjork J, Smedegard G. Acute microvascular effects of PAF-acether, as studied by intravital microscopy. Eur J Pharmacol. 1983;96:87-94.
11. Dillon PK, Fitzpatrick MF, Ritter AB, Duran WN. Effect of platelet-activating factor on leukocyte adhesion to microvascular endothelium: time course and dose-response relationships. Inflammation. 1988;12: 563-573.
12. Uhl E, Pickelmann S, Röhrich F, Baethmann A, Schürer L. Influence of platelet-activating factor on cerebral microcirculation in rats, part 2: systemic application. Stroke. 1999;30:873-879.
13. Heuer HO, Casals Stenzel J, Muacevic G, Weber KH. Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet activating factor. J Pharmacol Exp Ther. 1990;255: 962-968.
14. Zeintl H, Sack FU, Intaglietta M, Messmer K. Computer assisted leukocyte adhesion measurement in intravital microscopy. Int J Microcirc Clin Exp. 1989;8:293-302.
15. Muacevic G, Heuer HO. Platelet-activating factor antagonists in experimental shock. Arzneimittelforschung. 1992;42:1001-1004.
16. Armstead WM, Pourcyrous M, Mirro R, Leffler CW, Busija DW. Platelet activating factor: a potent constrictor of cerebral arterioles in newborn pigs. Circ Res. 1988;62:1-7.
17. Chiba Y, Mikoda N, Kawasaki H, Ito K. Endothelium-dependent relaxant action of platelet activating factor in the rat mesenteric artery. Naunyn Schmiedebergs Arch Pharmacol. 1990;341:68-73.
18. Lindsberg PJ, Jacobs TP, Paakkari IA, Hallenbeck JM, Feuerstein G. Effect of systemic platelet-activating factor (PAF) on the rabbit spinal cord microcirculation. J Lipid Mediat. 1990;2:41-58.
19. Lai F, Shepherd C, Cervoni P, Wissner A. Hypotensive and vasodilatory activity of (I) 1-O-octadecyl-2-acetyl-blycryl-3-phosphorocholine in the normotensive rat. Life Sci. 1983;32:1159-1166.
20. Edwards RM, Trizna W, Feuerstein G. Platelet-activating factor (PAF) has no direct effect on rat intracerebral arterioles in vitro. J Lipid Mediat. 1991;3:161-165.
21. Uski TK, Reinstrup P. Actions of platelet-activating factor on isolated feline and human cerebral arteries. J Cereb Blood Flow Metab. 1990;10: 428-431.
22. Feuerstein G, Siren AL. Platelet-activating factor and shock. Prog Biochem Pharmacol. 1988;22:181-190.
23. Namm DH, Tadepalli AS, High JA. Species specificity of the platelet response to 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine. Thromb Res. 1982;25:341-350.
24. Kumar R, Harvey SA, Kester M, Hanahan DJ, Olson MS. Production and effects of platelet-activating factor in the rat brain. Biochim Biophys Acta. 1988;963:375-383.
25. Bekker AY, Dillon PK, Paul J, Ritter AB, Duran WN. Dose-response relationships between platelet activating factor and permeability - surface area product of FITC-dextran 150 in the hamster cheek pouch. Microcirc Endothelium Lymphatics. 1988;4:433-446.
26. Grigorian GY, Ryan US. Platelet-activating factor effects on bovine pulmonary artery endothelial cells. Circ Res. 1987;61:389-395.
27. Bussolino F, Camussi G, Aglietta M, Braquet P, Bosia A, Pescarmona G, Sanavio F, D'Urso N, Marchisio PC. Human endothelial cells are target for platelet-activating factor, I: platelet-activating factor induces changes in cytoskeleton structures. J Immunol. 1987;139: 2439-2446.
28. Sawyer DB, Andersen OS. Platelet-activating factor is a general membrane perturbant. Biochim Biophys Acta. 1989;987:129-132.
29. Kochanek PM, Hallenbeck JM. Polymorphonuclear leukocytes and monocytes/macrophages in the pathogenesis of cerebral ischemia and stroke. Stroke. 1992;23:1367-1379.
30. Matsuo Y, Kihara T, Ikeda M, Ninomiya M, Onodera H, Kogure K. Role of neutrophils in radical production during ischemia and reperfusion of the rat brain: effect of neutrophil depletion on extracellular ascorbyl radical formation. J Cereb Blood Flow Metab. 1995;15:941-947.
31. Chopp M, Zhang RL, Chen H, Li Y, Jiang N, Rusche JR. Postischemic administration of an anti-Mac-1 antibody reduces ischemic cell damage after transient middle cerebral artery occlusion in rats. Stroke. 1994;25: 869-875.
32. Frerichs KU, Lindsberg PJ, Hallenbeck JM, Feuerstein GZ. Platelet-activating factor and progressive brain damage following focal brain injury. J Neurosurg. 1990;73:223-233.
33. Springer TA. Adhesion receptors of the immune system. Nature. 1990; 346:425-434.
34. Blank ML, Lee TC, Fitzgerald V, Snyder F. A specific acetylhydrolase for 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine (a hypotensive and platelet-activating lipid). J Biol Chem. 1981;256:175-178.